SAHPRA releases media statement on Pfizer adverse events, but ignores the letter of concern from South African doctors dated 16 February 2022

Transformative Health Justice
3 min readMar 15, 2022

SAHPRA’s press release 11 March 2022 includes the following statements:

  1. “The South Africa Health Products Regulatory Authority (SAHPRA) has noted that a safety report in relation to the COVID-19 Pfizer Comirnaty vaccine directed to the United States Food and Drug Administration (FDA) has been distributed on various communication platforms in South Africa. Pfizer’s “COMIRNATY” vaccine is authorised for use in South Africa by SAHPRA in adults and children aged 12 years and older.”
  2. “The safety report issued by Pfizer indicates all AESIs reported during the reporting period. However, not all AESIs included in the report are linked to the vaccine. As these vaccines are still new, their safety profiles are evolving and investigations are ongoing; hence the need for the continuous monitoring. Based on the latest periodically reported safety data reviewed by SAHPRA for Pfizer COVID-19 vaccines, the benefit-risk profile of this vaccine remains favourable and safe to be administered as per the roll-out schedule.”

“SAHPRA ensures that all health products, including vaccines, have undergone the requisite evaluation and assessments that meet regulatory requirement prior to being made available to the public. Safety is an important concern and no product, including vaccines, will be made available to the public if there are any indications that public safety will be compromised,” indicates SAHPRA CEO, Dr Boitumelo Semete-Makokotlela.

Read the full SAHPRA media release here:

Call to Action:

  1. SAHPRA will host a webinar to discuss vaccine safety and adverse events. Click here to register:

2.1. Watch the interview by Shabnam Palesa Mohamed with South African medical professionals speaking out about negative effects:

2.2. Read the South African medical professionals’ letter of concern:

2.3. Medical Professionals in South Africa, please support the letter of concern to SAHPRA, SAMA and HPCSA:

3.1. Report negative jab effects in South Africa to

3.2. If you applied for compensation or want to apply, fill in this survey:

4.1. Promote SA VAERS on social media to raise awareness

4.2. Email SA VAERS with ideas:

4.3. Donate so we can help more people: Account: Transformative Health Justice. Standard Bank. Account number: 1016 140 7062. Ref: SA VAERS

#SAVAERS #THJ #HumanRights #Right2Know #Right2Health #Right2Life #SouthAfrica